Corporate Headquarters
420 Stevens Avenue
Suite 370
Solana Beach, CA 92075

(858)345-1494 Tel.

Investor Relations :: Press Releases

All Releases
View Summary Evoke Pharma Announces $10 Million Registered Direct Offering Priced At-The-Market
Jul 29, 2016
PDF 11.6 KB
View Summary Evoke Pharma Receives Conditional FDA Acceptance of Proposed Brand Name for EVK-001
Jul 26, 2016
PDF 10.7 KB
View Summary Evoke Pharma Announces $4.5 Million At-The-Market Offering
Jul 20, 2016
PDF 11.3 KB
View Summary Evoke Pharma Reports Topline Results from EVK-001 Phase 3 Clinical Trial
Jul 18, 2016
PDF 13.2 KB
View Summary Evoke Advances Commercial Preparations for EVK-001 with inVentiv Agreement
Jul 7, 2016
PDF 11.6 KB
View Summary Evoke Advances Commercial Preparations for EVK-001 with inVentiv Agreement
Jul 7, 2016
PDF 12.5 KB
View Summary Evoke Completes Phase 3 Clinical Trial of EVK-001 in Women with Symptoms Associated with Diabetic Gastroparesis
Jun 1, 2016
PDF 12.4 KB
View Summary Evoke Pharma Presents Data from Successful Thorough ECG (TQT) Study of EVK-001 at Digestive Disease Week 2016
May 24, 2016
PDF 12.1 KB
View Summary Evoke Enters Exclusive Commercial Supply Agreement for Active Pharmaceutical Ingredient in EVK-001
May 19, 2016
PDF 11.7 KB
View Summary Evoke Pharma Reports First Quarter 2016 Results
May 11, 2016
PDF 18.3 KB
View Summary Evoke Pharma Schedules Webcast and Conference Call for First Quarter 2016 Financial Results
May 5, 2016
PDF 11.4 KB
View Summary Evoke Announces Timing of Phase 3 Results from its Recently Fully Enrolled Pivotal Clinical Trial of EVK-001
May 3, 2016
PDF 11.4 KB
View Summary Evoke Successfully Completes Phase 3 Clinical Trial Enrollment of EVK-001 in Women with Symptoms Associated with Diabetic Gastroparesis
Apr 25, 2016
PDF 13.1 KB
View Summary Evoke Pharma Reports Fourth Quarter and Year End 2015 Results
Mar 10, 2016
PDF 20.8 KB
View Summary Evoke Pharma Schedules Webcast and Conference Call for Fourth Quarter and Year End 2015 Financial Results
Mar 4, 2016
PDF 11.5 KB
View Summary Evoke Pharma Schedules Webcast and Conference Call for Fourth Quarter and Year End 2015 Financial Results
Mar 4, 2016
PDF 12.3 KB
View Summary Evoke Accelerates New Drug Application Process by Engaging Regulatory Experts
Mar 3, 2016
PDF 11.6 KB
View Summary Evoke Nears Completion of Phase 3 Clinical Trial Enrollment and Secures Extension to Credit Facility
Mar 1, 2016
PDF 11.4 KB
View Summary Evoke Nears Completion of Phase 3 Clinical Trial Enrollment and Secures Extension to Credit Facility
Mar 1, 2016
PDF 12.3 KB
View Summary Evoke Pharma to Present Results From Successful Thorough ECG (TQT) Study of EVK-001 at Digestive Disease Week 2016
Feb 17, 2016
PDF 11.9 KB
Showing 21-40 of 86 Page: 1 2 3 4 5  Previous 20 | Next 20